Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 4,987 | 7,395 | 4,703 | 5,590 | 5,376 |
| Operating Income | -4,987 | -7,395 | -4,703 | -5,590 | -5,376 |
| Other Income | 186 | 257 | 307 | 268 | 229 |
| Pre-tax Income | -4,801 | -7,138 | -4,396 | -5,322 | -5,147 |
| Income Tax | 11 | 11 | 10 | 9 | 8 |
| Net Income Continuous | -4,812 | -7,149 | -4,406 | -5,331 | -5,155 |
| Minority Interests | N/A | N/A | -13 | -72 | -66 |
| Net Income | $-4,812 | $-7,149 | $-4,393 | $-5,259 | $-5,090 |
| EPS Basic Total Ops | -0.15 | -0.24 | -0.15 | -0.22 | -0.24 |
| EPS Basic Continuous Ops | -0.14 | -0.24 | -0.15 | -0.23 | -0.25 |
| EPS Diluted Total Ops | -0.15 | -0.24 | -0.15 | -0.22 | -0.24 |
| EPS Diluted Continuous Ops | -0.14 | -0.24 | -0.15 | -0.23 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.24 | -0.15 | N/A | N/A |
| EBITDA(a) | $-4,946 | $-7,369 | $-4,678 | $-5,566 | $-5,373 |